OverviewChartNewsTraderScreen

Soc. Generale Knock-Out BION/  DE000SH4F029  /

Frankfurt Zert./SG
8/5/2024  9:41:36 PM Chg.+0.230 Bid9:50:35 PM Ask9:50:35 PM Underlying Strike price Expiration date Option type
3.610EUR +6.80% 3.610
Bid Size: 900		 3.670
Ask Size: 900		 BB BIOTECH N 72.6981 CHF 12/31/2078 Put
GlobeNewswire 4/2 Abivax reports 2023 financial results and operational update
GlobeNewswire 3/28 Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second ...
GlobeNewswire 11/27/2023 Arvinas Announces Oversubscribed $350 Million Private Placement
GlobeNewswire 3/8/2022 NEC OncoImmunity Acquires VAXIMM’s Neoantigen Vaccine Development Assets
GlobeNewswire 6/17/2021 Aleva Neurotherapeutics Recruits First Patient into its PMCF Study with its directSTIM™ Directional ...
TeleTrader 4/15/2021 Incidence of blood clots in Pfizer, Moderna, AZ vaccines similar- report
TeleTrader 4/14/2021 EU to get 50M Pfizer COVID vaccines in Q2 rather than Q4
TeleTrader 11/11/2020 Pfizer, BioNTech grant EU 200 million vaccine doses
GlobeNewswire 12/16/2019 Aleva Neurotherapeutics Receives CE Mark for its directSTIM™ Deep Brain Stimulation System and Raise...
GlobeNewswire 10/19/2018 Global Neurostimulation Devices Market Report 2018-2030: Focus on Invasive Devices Such as SCS, DBS,...
GlobeNewswire 1/2/2018 Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
GlobeNewswire 12/6/2017 Non-Antibody Protein Scaffolds Drugs and Diagnostics Market, 2030
GlobeNewswire 10/19/2017 Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
GlobeNewswire 12/2/2016 Successful launch of BB Healthcare Trust plc on the London Stock Exchange - initial issue volume GBP...
GlobeNewswire 10/21/2016 Biotech stocks continue to advance
GlobeNewswire 10/11/2016 BB BIOTECH AG : BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 10/11/2016 Ad hoc: BB Biotech AG with profit in the third quarter 2016
GlobeNewswire 7/29/2016 Bellevue Group with half-year operating profit of CHF 6.8 mn - increase of assets under management t...
GlobeNewswire 7/22/2016 BB Biotech: Stabilization of biotech sector in the second quarter of 2016
GlobeNewswire 7/15/2016 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 7/14/2016 BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
GlobeNewswire 7/11/2016 BB Biotech AG with after-tax loss in the first half year of 2016
GlobeNewswire 6/23/2016 BB Biotech AG :Release of the Home Member State according to Article 2c of the WpHG (the German Secu...
GlobeNewswire 4/22/2016 BB BIOTECH AG: Challenging first quarter for biotech investments
GlobeNewswire 4/13/2016 BB Biotech AG with after-tax loss in the first quarter of 2016